• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

TVM Capital Life Science Venture Capital

Investing in Life Science Innovation

  • About Us
    • Partners
  • Team
  • Senior Advisors
  • Portfolio
  • Funding Request
  • News
  • Events
  • ESG Policy
  • Contact

News

  • Home
  • About Us
  • Team
  • Senior Advisors
  • Portfolio
  • News
  • Events
  • ESG Policy
  • Contact

News · January 5, 2011

EUSA Pharma Announces Priority Review Status for ERWINAZE® BLA

Langhorne, PA and Oxford, UK – 5 January 2011 EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, today announced that its …

  • « Go to Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 29
  • Go to page 30
  • Go to page 31

Primary Sidebar

Secondary Sidebar

Additional News

Panthera D-SAD Classic oral appliance now eligible for Medicare reimbursement

August 1, 2022

Kent Imaging Recognized as Most Innovative Medical Imaging Technology Developer in Canada

June 23, 2022

Egg Medical hatches technology to shield health care workers from radiation

March 29, 2022

Egg Medical hatches $13M VC funding

March 15, 2022

Egg Medical, Inc., Closes on $13 million Financing

March 3, 2022

  • in

Copyright © 2023 · TVM Capital Life Science Venture Capital · ESG Disclosure · Privacy Policy · Contact